Showing results (41-50 of 71) with videos related to
Sort By:
Pageof 8
The Journal of Pediatrics|December 10, 2022
Cost-Effectiveness of Newborn Screening for Phenylketonuria and Congenital HypothyroidismKajsa Appelberg, Lene Sörensen, Rolf H Zetterström, et al.European Heart Journal. Digital Health|September 23, 2025
Cost-effectiveness of a clinical decision support system for atrial fibrillation: an RCT-based modelling studyOlof Persson Lindell, Martin Henriksson, Lars O Karlsson, et al.Journal of Medical Ethics|February 27, 2020
Do not despair about severity-yetMathias Barra, Mari Broqvist, Erik Gustavsson, et al.Health Care Analysis : HCA : Journal of Health Philosophy and Policy|May 24, 2019
Severity as a Priority Setting Criterion: Setting a Challenging Research AgendaMathias Barra, Mari Broqvist, Erik Gustavsson, et al.Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|August 27, 2013
Swedish experience-based value sets for EQ-5D health statesKristina Burström, Sun Sun, Ulf-G Gerdtham, et al.Pharmacoeconomics|April 21, 2020
Experience-Based Swedish TTO and VAS Value Sets for EQ-5D-5L Health StatesKristina Burström, Fitsum Sebsibe Teni, Ulf-G Gerdtham, et al.Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|October 10, 2021
Inequality and heterogeneity in health-related quality of life: findings based on a large sample of cross-sectional EQ-5D-5L data from the Swedish general populationFitsum Sebsibe Teni, Ulf-G Gerdtham, Reiner Leidl, et al.Primary Care Diabetes|April 9, 2017
Weight change patterns and healthcare costs in patients with newly-diagnosed type-2 diabetes in SwedenUgne Sabale, Johan Bodegard, Bodil Svennblad, et al.Plos One|March 25, 2021
Long term risk and costs of bleeding in men and women treated with triple antithrombotic therapy-An observational studyAnna Holm, Martin Henriksson, Joakim Alfredsson, et al.Primary Care Diabetes|January 30, 2015
Healthcare utilization and costs following newly diagnosed type-2 diabetes in Sweden: A follow-up of 38,956 patients in a clinical practice settingUgne Sabale, Johan Bodegård, Johan Sundström, et al.Pageof 8